Please note all code is open source and on github.
Work Stream 1:
We conducted two systematic reviews to identify models used for transport health impact assessment, and to synthesise results. Paper are due for submission by March 2022.
We published a tutorial on the application of Value of Information methods to health impact models in Epidemiologic Methods (Jackson et al 2021), along with an R package and full code.
Work Stream 2:
SILO-MITO-MATSim are integrated transport models for simulating land use, travel demand, and road network assignment. We have extended these models to represent more accurately health behaviours and exposures, to sum exposures for each individual, and to simulate health outcomes. The model has been set up for Munich and is being set up for Manchester.
Work Stream 3:
ITHIM-Global is a new version of The Integrated Transport and Health Impact Model created for GLASST. Sufficient data for modelling the three health pathways (physical activity, road traffic injuries, air pollution) has been fully processed and we are analysing results for 20 cities in Latin America, 5 cities in Africa, and 3 cities in India.
Travel behaviours We have collated and harmonised anonymised travel survey datasets for 50 cities (across 17 different countries), and published two papers, one comparing cycling levels and one comparing gender differences in active travel.
Road traffic injury data We accessed and harmonised datasets of case-level road fatalities from multiple settings 76 cities from Latin America, North America, Africa, and Europe.
Air emissions and pollution data We are working with the European Commission’s Joint Research Centre (JRC) to use the EDGAR emissions database for impact modelling.
Health impact modelling methods We have implemented the proportional multi-state life table model in R. We have made advances in methods and software for modelling chronic disease burden from limited disease data (paper submitted).
Dose response functions: We undertook systematic reviews, including extensive exposure harmonisation and dose response meta-analyses for a wide range of diseases. This work is being published in three papers. Firstly, all-cause mortality, cardiovascular diseases, and 11 cancers. Secondly, depression. Thirdly, dementias and Parkinson’s disease.